v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current Assets    
Cash $ 24,779 $ 2,856
Accounts receivable, net 29,898 323,965
Inventories 273,155 273,195
Prepaid and other current assets 205,684 226,217
Assets of discontinued operations 468 4,048
Total current assets 533,984 830,281
Property and equipment, net 75,915 78,094
Assets of discontinued operations, net 136,440 140,563
TOTAL ASSETS 746,339 1,048,938
Current Liabilities    
Accounts payable and accrued expenses 1,808,244 1,642,518
Liabilities of discontinued operations 95,649 150,652
Unsecured convertible debentures, net of discount 396,664 357,528
Notes payable to related parties 240,000   
Notes payable 3,867,330 3,830,637
Total current liabilities 6,407,887 5,981,335
Notes payable, net of current portion. 8,849 25,882
Notes payable to related parties, net of current portion 727,000 477,000
Unsecured convertible debentures, net of current portion and discount 1,102,290 1,142,472
Unsecured convertible debentures-related party, net of current portion and discount      
Derivative liability 185,397 312,088
Warrant liability 759,749 1,060,353
TOTAL LIABILITIES 9,191,172 8,999,130
Commitments and Contingencies (see Note 8)      
Series D redeemable convertible preferred stock; par value $0.001 per share;15,000 shares authorized, 1,926 and 1,070 issued and outstanding, respectively 3,177,526 2,515,469
Assured Pharmacy, Inc. Stockholders' Deficit    
Preferred stock; par value $0.001 per share; 5,000,000 shares authorized, 2,830 shares designated to Series A convertible, 7,745 shares designated to Series B convertible, 813 shares designated to Series C convertible      
Series A convertible preferred stock; par value $0.001 per share; 2,830 shares authorized, 1,466 and 1,466 issued and outstanding, respectively 1 1
Series C convertible preferred stock; par value $0.001 per share; 813 shares authorized, 813 and 813 issued and outstanding, respectively 1 1
Series B convertible preferred stock; par value $0.001 per share; 7,745 shares authorized, 5,124 and 5,124 issued and outstanding, respectively 5 5
Common stock; par value $0.001 per share; 35,000,000 shares authorized, 11,503,294 and 10,255,693 issued and outstanding, respectively 11,503 10,256
Additional paid-in capital, net 38,319,672 38,142,048
Accumulated deficit (49,953,541) (48,617,972)
Stockholders' deficit (11,622,359) (10,465,661)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 746,339 $ 1,048,938